Co-Design in Healthcare: A Foundation for Scalable, Trustworthy Digital Platforms
Digital health solutions increasingly promise to transform healthcare delivery—improving access, efficiency, and outcomes at scale. Yet many platforms fail to progress beyond pilot stages or struggle with real-world adoption. A consistent root cause is not technical immaturity, but insufficient alignment with the needs, workflows, and values of those who use and are affected by these systems. Co-design has emerged as a critical approach to addressing this gap and enabling scalable, sustainable digital health platforms.
What Is Co-Design in Healthcare?
Co-design (also referred to as participatory or experience-based design) is a collaborative process in which end users—patients, carers, clinicians, and other stakeholders—are actively involved throughout the design and development lifecycle. Rather than being consulted at the end, users help define problems, shape solutions, and test iterations from the outset. In healthcare, this approach recognises that lived experience and clinical expertise are as important as technical or commercial considerations (Sanders & Stappers, 2008).
The healthcare context is uniquely complex. Clinical risk, ethical considerations, regulatory requirements, and deeply embedded workflows mean that solutions designed in isolation often fail when deployed. Co-design helps surface tacit knowledge—unwritten practices, workarounds, and contextual constraints—that are rarely captured through requirements documents alone (Bate & Robert, 2007).
Why Co-Design Matters for Adoption and Safety
Adoption is a primary determinant of impact in digital health. Evidence shows that interventions perceived as misaligned with clinical workflows or patient priorities are more likely to be abandoned, regardless of their technical merit (Greenhalgh et al., 2017). Co-design directly addresses this by ensuring solutions are usable, acceptable, and meaningful to users.
From a safety perspective, co-design also plays a preventive role. Engaging clinicians and patients early helps identify unintended consequences, usability risks, and data interpretation issues before deployment. This aligns with the growing recognition that digital health tools should be treated as socio-technical systems, where human factors are integral to safety and effectiveness (Carayon et al., 2015).
Co-Design as an Enabler of Scalability
While co-design is sometimes perceived as time-consuming or incompatible with scale, the opposite is often true. Platforms that fail to incorporate co-design frequently require extensive rework, customisation, or change management when scaling to new settings. In contrast, co-designed platforms tend to embed flexibility, configurability, and interoperability from the beginning.
Scalability in healthcare is not merely about handling more users; it involves adapting to diverse populations, clinical contexts, and organisational structures. Co-design supports this by engaging a broad range of stakeholders across settings—urban and rural, primary and tertiary care, digitally literate and digitally excluded populations. This diversity helps ensure that core platform assumptions remain valid across contexts (O’Cathain et al., 2019).
Moreover, co-design strengthens trust. Trust is essential for scaling digital health platforms that rely on sensitive health data, algorithmic decision support, or behaviour change interventions. Transparent collaboration with users fosters legitimacy and social licence, which are increasingly recognised as prerequisites for sustainable digital health innovation (Floridi et al., 2018).
From Co-Design to Continuous Co-Evolution
Importantly, co-design should not be viewed as a one-off phase. Scalable platforms require continuous learning and adaptation as clinical evidence evolves, regulations change, and user needs shift. Embedding ongoing feedback loops—through analytics, qualitative insights, and governance structures—extends co-design into a process of co-evolution.
This aligns well with agile and learning health system paradigms, where data from real-world use informs iterative improvement (Friedman et al., 2017). Platforms designed with co-design principles are better positioned to evolve without losing alignment with user needs or compromising safety.
Conclusion
Co-design is no longer optional in healthcare innovation; it is foundational. For digital health platforms aiming to scale responsibly, co-design offers a structured way to align technology with human, clinical, and organisational realities. By improving adoption, enhancing safety, and enabling adaptability across contexts, co-design transforms digital health from isolated tools into trusted, scalable systems of care.
For organisations building the next generation of digital health platforms, investing in co-design is not a cost—it is a risk-reduction strategy and a prerequisite for meaningful scale.
References
Bate, P., & Robert, G. (2007). Bringing user experience to healthcare improvement: The concepts, methods and practices of experience-based design. Health Services Management Research, 20(2), 84–92.
Carayon, P., et al. (2015). Sociotechnical systems analysis in healthcare: A research agenda. BMJ Quality & Safety, 24(1), 1–6.
Floridi, L., et al. (2018). AI4People—An ethical framework for a good AI society. Minds and Machines, 28, 689–707.
Friedman, C. P., et al. (2017). Toward a science of learning systems: A research agenda for the high-functioning Learning Health System. Journal of the American Medical Informatics Association, 24(1), 43–50.
Greenhalgh, T., et al. (2017). Beyond adoption: A new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up of health technologies. Journal of Medical Internet Research, 19(11), e367.
O’Cathain, A., et al. (2019). Mixed methods research for patient-centred outcomes research. Journal of Patient-Reported Outcomes, 3, 18.
Sanders, E. B.-N., & Stappers, P. J. (2008). Co-creation and the new landscapes of design. CoDesign, 4(1), 5–18.